Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,073.81 -3.17 (-0.29%)
Streaming Delayed Price Updated: 2:38 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 574,750
Open 1,076.98
Bid (Size) 1,073.58 (80)
Ask (Size) 1,074.06 (80)
Prev. Close 1,076.98
Today's Range 1,068.30 - 1,081.39
52wk Range 623.78 - 1,111.99
Shares Outstanding 956,580,893
Dividend Yield 0.56%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Should You Invest in Ozempic Maker Novo Nordisk in 2026? ↗
The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back. 
Via The Motley Fool
News headline image
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026 ↗
Via MarketBeat

Performance

YTD
+38.0%
+38.0%
1 Month
-3.3%
-3.3%
3 Month
+50.3%
+50.3%
6 Month
+35.1%
+35.1%
1 Year
+35.2%
+35.2%

More News

Read More
News headline image
The Ghost Town Effect: How Thin Holiday Liquidity is Jolting US Equities
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Sector Rotation: 2 Smart Money Moves for 2026 ↗
Via MarketBeat
News headline image
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling ↗
Via Stocktwits
News headline image
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree ↗
Via The Motley Fool
News headline image
The Biological Turing Point: How AlphaFold 3 and the Nobel Prize Redefined the Future of Medicine
Via TokenRing AI
Topics Artificial Intelligence Initial Public Offering
News headline image
The Great Broadening: How AI Implementation Reshaped the Non-Tech Bottom Line in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? ↗
Via The Motley Fool
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
Via PredictStreet
Topics Economy Intellectual Property World Trade
News headline image
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
Via PredictStreet
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
Via PredictStreet
Topics Economy Government Intellectual Property
News headline image
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
Via Barchart.com
Topics Workforce
News headline image
Eli Lilly & Co (NYSE:LLY) Presents a Compelling Growth at a Reasonable Price (GARP) Case ↗
Via Chartmill
News headline image
3 Hyped Up Stocks with Warning Signs
Via StockStory
News headline image
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Atomic Architect: How University of Washington’s Generative AI Just Rewrote the Rules of Medicine
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Delphi-2M Breakthrough: AI Now Predicts 1,200 Diseases Decades Before They Manifest
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
Via PredictStreet
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
Via PredictStreet
Topics Economy
News headline image
Novo Nordisk (NVO) Research: The Oral Wegovy Pivot and the 2026 Outlook
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking ↗
Via Stocktwits
News headline image
Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage
Via Newsfile
News headline image
Top 5 US Healthcare Stocks By Market Value ↗
Via Stocktwits

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,073.81
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 12/26/25 02:38 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,027.19B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,027B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.